Leptin, cardiovascular diseases and type 2 diabetes mellitus

N Katsiki, DP Mikhailidis, M Banach - Acta Pharmacologica Sinica, 2018 - nature.com
Leptin, an adipokine that is implicated in the control of food intake via appetite suppression,
may also stimulate oxidative stress, inflammation, thrombosis, arterial stiffness …

Fundamentals, recent advances, and future challenges in bioimpedance devices for healthcare applications

D Naranjo-Hernández, J Reina-Tosina… - Journal of …, 2019 - Wiley Online Library
This work develops a thorough review of bioimpedance systems for healthcare applications.
The basis and fundamentals of bioimpedance measurements are described covering issues …

Emerging biomarkers for early detection of chronic kidney disease

M Mizdrak, M Kumrić, TT Kurir, J Božić - Journal of personalized …, 2022 - mdpi.com
Chronic kidney disease (CKD) is a major and serious global health problem that leads to
kidney damage as well as multiple systemic diseases. Early diagnosis and treatment are two …

Epidemiology of end-stage kidney disease

R Gupta, K Woo, AY Jeniann - Seminars in vascular surgery, 2021 - Elsevier
End-stage kidney disease (ESKD) is a common and morbid disease that affects patients'
quality and length of life, representing a large portion of health care expenditure in the …

Multi-omics approaches for revealing the complexity of cardiovascular disease

S Doran, M Arif, S Lam, A Bayraktar… - Briefings in …, 2021 - academic.oup.com
The development and progression of cardiovascular disease (CVD) can mainly be attributed
to the narrowing of blood vessels caused by atherosclerosis and thrombosis, which induces …

Anticoagulation in chronic kidney disease: from guidelines to clinical practice

V Aursulesei, II Costache - Clinical cardiology, 2019 - Wiley Online Library
Background Chronic kidney disease (CKD) is a major global public health problem, being
closely connected to cardiovascular disease. CKD involves an elevated thromboembolic risk …

Chronic kidney disease among adult participants of the ELSA-Brasil cohort: association with race and socioeconomic position

SM Barreto, RM Ladeira, BB Duncan… - J epidemiol community …, 2016 - jech.bmj.com
Background There is increased interest in understanding why chronic kidney disease (CKD)
rates vary across races and socioeconomic groups. We investigated the distribution of …

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins

L Hernandez, LJ Ward, S Arefin, T Ebert… - Scientific reports, 2022 - nature.com
Kidney failure and associated uraemia have implications for the cardiovascular system,
brain, and blood–brain barrier (BBB). We aim to examine BBB disruption, by assessing brain …

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

L Gaziano, L Sun, M Arnold, S Bell, K Cho… - Circulation, 2022 - Am Heart Assoc
Background: End-stage renal disease is associated with a high risk of cardiovascular
events. It is unknown, however, whether mild-to-moderate kidney dysfunction is causally …

Birth weight, gestational age, and risk of cardiovascular disease in early adulthood: influence of familial factors

D Lu, Y Yu, JF Ludvigsson, AS Oberg… - American Journal of …, 2023 - academic.oup.com
The association between intrauterine growth restriction and cardiovascular disease (CVD)
later in life might be confounded by familial factors. We conducted a binational register …